Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting
- Author:
Riyaz BHIKOO
1
;
Erika M DAMATO
;
Stephen GUEST
;
Jo SIMS
Author Information
- Publication Type:Original Article
- Keywords: Ocular toxoplasmosis; Uveitis
- MeSH: Cicatrix; Diagnosis; Follow-Up Studies; Humans; Immunoglobulin M; Inflammation; New Zealand; Optic Nerve; Recurrence; Retinitis; Retrospective Studies; Toxoplasmosis; Toxoplasmosis, Ocular; Uveitis; Uveitis, Posterior; Vasculitis; Visual Acuity
- From:Korean Journal of Ophthalmology 2019;33(6):514-519
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: This study sought to describe the different clinical features and presentations of primary ocular toxoplasmosis in a setting not demonstrating an outbreak of disease.METHODS: This was a retrospective review of patients presenting to uveitis management services in Auckland and Hamilton, New Zealand between 2003 to 2018 with uveitis and positive toxoplasmosis immunoglobulin M serology.RESULTS: We identified 16 patients with primary acquired toxoplasmosis infection and ocular involvement. The mean age was 53 years. Systemic symptoms were reported in 56% (9 / 16). Visual acuity was reduced to 20 / 30 or less in 50% of patients (8 / 16). A single focus of retinitis without a pigmented scar was the salient clinical feature in 69% (11 / 16). Optic nerve inflammation was the sole clinical finding in 19% (3 / 16). Bilateral arterial vasculitis was the sole clinical finding in 13% (2 / 16). A delay in the diagnosis of toxoplasmosis of more than two weeks occurred in 38% (6 / 16) due to an initial alternative diagnosis. Antibiotic therapy was prescribed in all cases. Vision was maintained or improved in 69% (11 / 16) at the most recent follow-up visit (15 months to 10 years). Relapse occurred in 69% (11 / 16), typically within four years from the initial presentation.CONCLUSIONS: Primary ocular toxoplasmosis presenting in adulthood is a relatively uncommon cause of posterior uveitis in New Zealand. This condition should be considered in any patient presenting with retinitis or optic nerve inflammation without a retinochoroidal scar. This disease tends to relapse; thus, close follow-up is required.
